文献速递主动脉外科

分支支架吻合冷冻象鼻修复术:医师发起的试验性器械豁免研究的早期结果

Branched stented anastomosis frozen elephant trunk repair: Early results from a physician-sponsored investigational device exemption study.
PubMed 文献 · J Thorac Cardiovasc Surg · 2023-10-05

这项前瞻性、单中心、非随机研究纳入178例多节段主动脉疾病患者,接受B-SAFER技术行全主动脉弓置换。主要安全终点为手术死亡、致残性卒中和下肢轻瘫/瘫痪,手术死亡10例(5.6%),致残性卒中5例(2.9%),下肢轻瘫1例。作者认为该技术安全可重复,需进一步随访分析和开发新器械。

要点

  • B-SAFER技术用于多节段主动脉疾病的全弓置换,手术死亡10例(5.6%),致残性卒中5例(2.9%),下肢轻瘫1例。
  • 178例患者中急性主动脉综合征73例、慢性夹层动脉瘤68例、退行性动脉瘤33例、先天性弓部疾病4例。
  • 估计生存率30天95%、90天88%、6个月84%、1年79%,1年生存率因适应证而异。

核心结论

  • B-SAFER技术用于多种手术指征的复杂队列全弓置换是安全且可重复的手术,早期结果来自一项包容性很强的医师发起试验性器械豁免研究。
  • 需要进一步随访和分析以完善该技术,并应开发用于该手术的新器械。

研究设计与样本

  • 前瞻性、单中心、非随机研究,纳入接受B-SAFER手术的患者:急性主动脉综合征73例、慢性主动脉夹层动脉瘤68例、退行性主动脉瘤33例、先天性主动脉弓疾病4例。
  • 装置在低温循环停止下顺行输送,弓部重建方式为单吻合单支架(SASS)70例、单吻合多支架(SAMA)68例、多吻合单支架(MASS)21例、多吻合多支架(MAMS)16例。
  • 主要安全终点为手术死亡、致残性卒中和下肢轻瘫/瘫痪。

主要发现

  • 2021年5月27日至2022年12月31日期间,178例患者接受B-SAFER手术,中位年龄65岁(范围21至85岁),女性52例(29%)。
  • 中位体外循环时间188分钟(四分位距155至226分钟),97%的患者采用顺行脑灌注进行修复,中位时间46分钟(四分位距38至61分钟)。
  • 手术死亡10例(5.6%,包括急性夹层6例[8.2%]、慢性夹层2例[2.9%]、退行性动脉瘤2例[6.1%]、先天性疾病0例),致残性卒中5例(2.9%),下肢轻瘫1例。
  • 其他严重并发症包括呼吸衰竭20例(11.4%)和急性肾损伤18例(10%)。
  • 32例患者(18%)接受了二期修复(28例血管内和4例开放),该手术后1例手术死亡由远端破裂导致;估计生存率30天95%、90天88%、6个月84%、1年79%;1年生存率因适应证而异:急性夹层72%、慢性夹层91%、退行性动脉瘤71%、先天性疾病100%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Multisegment thoracic aortic disease typically requires total aortic arch replacement, affects a heterogenous population, and carries a high risk even at centers of excellence. Risk has been associated with the duration of operation and complexity of repair. A novel branched stented anastomosis frozen elephant trunk repair (B-SAFER) technique has been developed at our center and is currently being studied as a physician-sponsored investigation device exemption (PS-IDE). OBJECTIVE: This study aimed to assess the early safety of using this investigational technique to treat the proximal aorta in subjects with aortic disease involving multiple segments. METHODS: This prospective, single center, nonrandomized study enrolled patients undergoing B-SAFER for acute aortic syndrome (n = 73), aortic aneurysm with chronic aortic dissection (n = 68), degenerative aortic aneurysm (n = 33), or congenital aortic arch disease (n = 4). Devices are delivered antegrade under hypothermic circulatory arrest, and the arch reconstruction is performed as a single anastomosis single stent (SASS; n = 70), single anastomosis multiple stent (SAMA; n = 68), multiple anastomosis single stent (MASS; n = 21), or multiple anastomosis multiple stent (MAMS; n = 16) reconstruction. The primary safety endpoints were operative mortality, disabling stroke, and paraparesis/paralysis. RESULTS: Between May 27, 2021, and December 31, 2022, 178 patients underwent B-SAFER in the configurations and for the indications as described above. The median patient age was 65 years (range, 21 to 85 years), and 52 (29%) were female. The median cardiopulmonary bypass time was 188 minutes (interquartile range [IQR], 155 to 226 minutes), and 97% of the patients underwent repair with antegrade brain perfusion for a median of 46 minutes (IQR, 38 to 61 minutes). Operative mortality occurred in 10 patients (5.6%, including 6 [8.2%] with acute dissection, 2 [2.9%] with chronic dissection, 2 [6.1%] with degenerative aneurysm, and 0 with a congenital disorder), disabling stroke in 5 patients (2.9%), and paraparesis in 1 patient. Other serious complications included respiratory failure (n = 20; 11.4%) and acute kidney injury (n = 18; 10%). Thirty-two patients (18%) had undergone second-stage repairs (28 endovascular and 4 open), with 1 operative mortality after that procedure due to distal rupture. Estimated survival was 95% at 30 days, 88% at 90 days, 84% at 6 months, and 79% at 1 year. One-year survival differed by indication (72% for acute dissection, 91% for chronic dissection, 71% for degenerative aneurysm, and 100% for congenital disorders). CONCLUSIONS: The B-SAFER technique for total arch replacement in a complex cohort of patients with various indications for surgery is a safe and reproducible operation, as demonstrated by the early results from a very inclusive PS-IDE study. Further follow-up and analysis will help refine the technique. Novel devices to perform this procedure should be developed.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Roselli EE, Vargo PR, Bakaeen F, et al. Branched stented anastomosis frozen elephant trunk repair: Early results from a physician-sponsored investigational device exemption study. J Thorac Cardiovasc Surg. 2023. PMID: 37802330. doi:10.1016/j.jtcvs.2023.09.069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。